O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+33.09%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$7.07B
AUM Growth
+$7.07B
(+20%)
Cap. Flow
-$90.9M
Cap. Flow
% of AUM
-1.29%
Top 10 Holdings %
Top 10 Hldgs %
31.27%
Holding
162
New
21
Increased
29
Reduced
28
Closed
28
Top Buys
| 1 |
BNR
Burning Rock Biotech
BNR
|
$128M |
| 2 |
Repare Therapeutics
RPTX
|
$106M |
| 3 |
Oric Pharmaceuticals
ORIC
|
$98.6M |
| 4 |
Biogen
BIIB
|
$63M |
| 5 |
Keros Therapeutics
KROS
|
$63M |
Top Sells
| 1 |
Ascendis Pharma
ASND
|
$255M |
| 2 |
Gilead Sciences
GILD
|
$98.4M |
| 3 |
Pfizer
PFE
|
$98.3M |
| 4 |
HCA Healthcare
HCA
|
$63.8M |
| 5 |
Stryker
SYK
|
$61.8M |
Sector Composition
| 1 | Healthcare | 97.61% |
| 2 | Financials | 1.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Applied Therapeutics
APLT
$71M
| $44M | 0.62% | 1,217,678 -102,199 | -8% | -$3.69M |
|
52
uniQure
QURE
$896M
| $43.7M | 0.61% | 969,079 -14,900 | -2% | -$671K |
|
53
Thermo Fisher Scientific
TMO
$186B
| $40M | 0.56% | 110,300 | – | – |
|
54
TELA Bio
TELA
$70.5M
| $39.2M | 0.55% | 3,027,542 | – | – |
|
55
Spyre Therapeutics
SYRE
$996M
| $37.1M | 0.52% | 4,015,524 +1,150,000 | +40% | +$10.6M |
|
56
Prothena Corp
PRTA
$441M
| $37.1M | 0.52% | 3,544,475 +642,236 | +22% | +$6.72M |
|
57
Edwards Lifesciences
EW
$47.8B
| $36.7M | 0.52% | 530,400 +353,600 | +200% | +$24.4M |
|
|
ALPN
58
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $35.6M | 0.5% | 3,670,955 | – | – |
|
59
scPharmaceuticals
SCPH
$295M
| $35.3M | 0.5% | 4,797,148 +1,387,283 | +41% | +$10.2M |
|
|
NSTG
60
DELISTED
NanoString Technologies, Inc.
NSTG
| $35M | 0.49% | 1,192,400 | – | – |
|
61
Acadia Healthcare
ACHC
$2.12B
| $34.7M | 0.49% | 1,380,160 | – | – |
|
62
SelectQuote
SLQT
$391M
| $31.8M | 0.45% | +1,255,000 | New | +$31.8M |
|
63
Xenon Pharmaceuticals
XENE
$2.98B
| $31.3M | 0.44% | 2,497,917 +835,105 | +50% | +$10.5M |
|
|
HARP
64
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $30.5M | 0.43% | 1,835,704 -610,705 | -25% | -$10.1M |
|
65
Inspire Medical Systems
INSP
$2.77B
| $30.2M | 0.43% | 347,000 | – | – |
|
66
Vaxcyte
PCVX
$4B
| $26.9M | 0.38% | +850,000 | New | +$26.9M |
|
|
IMMU
67
DELISTED
Immunomedics Inc
IMMU
| $26.9M | 0.38% | +757,900 | New | +$26.9M |
|
|
SVA
68
DELISTED
Sinovac Biotech, Ltd
SVA
| $25.5M | 0.36% | 2,839,500 | – | – |
|
69
IQVIA
IQV
$32.4B
| $24.8M | 0.35% | 175,000 | – | – |
|
70
Teva Pharmaceuticals
TEVA
$21.1B
| $23.9M | 0.34% | +1,935,200 | New | +$23.9M |
|
|
FLXN
71
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $22.1M | 0.31% | 1,684,000 +1,551,000 | +1,166% | +$20.4M |
|
72
SI-BONE Inc
SIBN
$719M
| $22M | 0.31% | 1,381,300 | – | – |
|
73
Novo Nordisk
NVO
$251B
| $21.6M | 0.3% | 330,000 | – | – |
|
74
Amgen
AMGN
$155B
| $21.6M | 0.3% | 91,500 -13,700 | -13% | -$3.23M |
|
75
Zymeworks
ZYME
$1.12B
| $21M | 0.3% | 582,302 | – | – |
|